CN108785617B - 一种治疗股骨头缺血性坏死的中药 - Google Patents
一种治疗股骨头缺血性坏死的中药 Download PDFInfo
- Publication number
- CN108785617B CN108785617B CN201811071479.2A CN201811071479A CN108785617B CN 108785617 B CN108785617 B CN 108785617B CN 201811071479 A CN201811071479 A CN 201811071479A CN 108785617 B CN108785617 B CN 108785617B
- Authority
- CN
- China
- Prior art keywords
- parts
- root
- femoral head
- traditional chinese
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 46
- 208000007875 Femur Head Necrosis Diseases 0.000 title abstract description 6
- 239000010975 amethyst Substances 0.000 claims abstract description 28
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 17
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 17
- 239000002994 raw material Substances 0.000 claims abstract description 17
- 241000123589 Dipsacus Species 0.000 claims abstract description 16
- 241000334160 Isatis Species 0.000 claims abstract description 16
- 241000893536 Epimedium Species 0.000 claims abstract description 15
- 235000018905 epimedium Nutrition 0.000 claims abstract description 15
- 240000009138 Curcuma zedoaria Species 0.000 claims abstract description 14
- 235000003405 Curcuma zedoaria Nutrition 0.000 claims abstract description 12
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 claims abstract description 12
- 235000019509 white turmeric Nutrition 0.000 claims abstract description 12
- 229940107666 astragalus root Drugs 0.000 claims abstract description 11
- 239000000463 material Substances 0.000 claims abstract description 11
- 238000002156 mixing Methods 0.000 claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000005556 hormone Substances 0.000 claims abstract description 8
- 229940088597 hormone Drugs 0.000 claims abstract description 8
- 238000002791 soaking Methods 0.000 claims abstract description 7
- 238000010438 heat treatment Methods 0.000 claims abstract description 3
- 208000034133 primary 1 avascular necrosis of femoral head Diseases 0.000 claims description 13
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims description 12
- 241001116742 Drynaria Species 0.000 claims description 11
- 230000003054 hormonal effect Effects 0.000 claims description 11
- 239000002775 capsule Substances 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 5
- 239000008187 granular material Substances 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 241000304195 Salvia miltiorrhiza Species 0.000 claims 3
- 206010031264 Osteonecrosis Diseases 0.000 abstract description 15
- 208000030016 Avascular necrosis Diseases 0.000 abstract description 5
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 4
- 208000015813 Familial avascular necrosis of femoral head Diseases 0.000 abstract description 3
- 240000007164 Salvia officinalis Species 0.000 abstract description 2
- 239000000203 mixture Substances 0.000 abstract description 2
- 235000005412 red sage Nutrition 0.000 abstract description 2
- 206010028851 Necrosis Diseases 0.000 description 26
- 230000017074 necrotic cell death Effects 0.000 description 26
- 210000000988 bone and bone Anatomy 0.000 description 25
- 210000004369 blood Anatomy 0.000 description 23
- 239000008280 blood Substances 0.000 description 23
- 230000000694 effects Effects 0.000 description 19
- 208000002193 Pain Diseases 0.000 description 18
- 230000036407 pain Effects 0.000 description 18
- 210000004394 hip joint Anatomy 0.000 description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
- 201000010099 disease Diseases 0.000 description 11
- 238000001035 drying Methods 0.000 description 11
- 230000017531 blood circulation Effects 0.000 description 10
- 238000001354 calcination Methods 0.000 description 10
- 239000004927 clay Substances 0.000 description 10
- 230000006870 function Effects 0.000 description 10
- 238000010791 quenching Methods 0.000 description 10
- 239000004576 sand Substances 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 10
- 230000007812 deficiency Effects 0.000 description 9
- 210000003734 kidney Anatomy 0.000 description 9
- 230000001737 promoting effect Effects 0.000 description 9
- 230000000171 quenching effect Effects 0.000 description 9
- 244000132619 red sage Species 0.000 description 9
- 235000006533 astragalus Nutrition 0.000 description 8
- 235000021419 vinegar Nutrition 0.000 description 8
- 239000000052 vinegar Substances 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 7
- 238000011160 research Methods 0.000 description 7
- 208000006820 Arthralgia Diseases 0.000 description 6
- 241001061264 Astragalus Species 0.000 description 6
- 239000009636 Huang Qi Substances 0.000 description 6
- 239000010231 banlangen Substances 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 238000000227 grinding Methods 0.000 description 6
- 230000001976 improved effect Effects 0.000 description 6
- 230000008439 repair process Effects 0.000 description 6
- 238000007873 sieving Methods 0.000 description 6
- 210000004233 talus Anatomy 0.000 description 6
- 235000019640 taste Nutrition 0.000 description 6
- 231100000331 toxic Toxicity 0.000 description 6
- 230000002588 toxic effect Effects 0.000 description 6
- 210000004204 blood vessel Anatomy 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 238000004140 cleaning Methods 0.000 description 5
- 230000000302 ischemic effect Effects 0.000 description 5
- 238000010025 steaming Methods 0.000 description 5
- 230000000472 traumatic effect Effects 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- 230000001154 acute effect Effects 0.000 description 4
- 238000007605 air drying Methods 0.000 description 4
- 230000008468 bone growth Effects 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 230000001076 estrogenic effect Effects 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 230000033001 locomotion Effects 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 210000002997 osteoclast Anatomy 0.000 description 4
- 239000009750 xian ling gu bao Substances 0.000 description 4
- 208000010392 Bone Fractures Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 241000405414 Rehmannia Species 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000015271 coagulation Effects 0.000 description 3
- 238000005345 coagulation Methods 0.000 description 3
- 239000008236 heating water Substances 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 230000001788 irregular Effects 0.000 description 3
- 208000030175 lameness Diseases 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000001338 necrotic effect Effects 0.000 description 3
- 230000011164 ossification Effects 0.000 description 3
- 201000008482 osteoarthritis Diseases 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 240000000031 Achyranthes bidentata Species 0.000 description 2
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- 208000036487 Arthropathies Diseases 0.000 description 2
- 241000045403 Astragalus propinquus Species 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010007882 Cellulitis Diseases 0.000 description 2
- 241000759833 Cornus officinalis Species 0.000 description 2
- 235000014375 Curcuma Nutrition 0.000 description 2
- 244000164480 Curcuma aromatica Species 0.000 description 2
- 235000002722 Dioscorea batatas Nutrition 0.000 description 2
- 235000006536 Dioscorea esculenta Nutrition 0.000 description 2
- 240000001811 Dioscorea oppositifolia Species 0.000 description 2
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 description 2
- 206010017076 Fracture Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 2
- 235000017443 Hedysarum boreale Nutrition 0.000 description 2
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 2
- 206010019468 Hemiplegia Diseases 0.000 description 2
- 208000004044 Hypesthesia Diseases 0.000 description 2
- 208000017170 Lipid metabolism disease Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 102100031475 Osteocalcin Human genes 0.000 description 2
- 108090000573 Osteocalcin Proteins 0.000 description 2
- 208000001132 Osteoporosis Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 241001522129 Pinellia Species 0.000 description 2
- 244000197580 Poria cocos Species 0.000 description 2
- 235000008599 Poria cocos Nutrition 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 2
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 2
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000010100 anticoagulation Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000037182 bone density Effects 0.000 description 2
- 230000004097 bone metabolism Effects 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000002405 diagnostic procedure Methods 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 2
- 210000004013 groin Anatomy 0.000 description 2
- 208000012285 hip pain Diseases 0.000 description 2
- 208000034783 hypoesthesia Diseases 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 210000000963 osteoblast Anatomy 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 238000011541 total hip replacement Methods 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 241000132012 Atractylodes Species 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 240000007311 Commiphora myrrha Species 0.000 description 1
- 235000006965 Commiphora myrrha Nutrition 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 206010019196 Head injury Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000018565 Hemochromatosis Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010023204 Joint dislocation Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 208000006670 Multiple fractures Diseases 0.000 description 1
- 208000023178 Musculoskeletal disease Diseases 0.000 description 1
- 206010052904 Musculoskeletal stiffness Diseases 0.000 description 1
- 235000007265 Myrrhis odorata Nutrition 0.000 description 1
- 241000283966 Pholidota <mammal> Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000002449 bone cell Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000001612 chondrocyte Anatomy 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000002591 computed tomography Methods 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 210000003989 endothelium vascular Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 208000020089 femoral neck fracture Diseases 0.000 description 1
- 210000002391 femur head Anatomy 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 208000006278 hypochromic anemia Diseases 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 230000006749 inflammatory damage Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 230000008407 joint function Effects 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 210000004409 osteocyte Anatomy 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 208000037922 refractory disease Diseases 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000002784 sclerotic effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 208000026843 stiff neck Diseases 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 229940037128 systemic glucocorticoids Drugs 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 201000005665 thrombophilia Diseases 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
- A61K36/126—Drynaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
- A61K36/296—Epimedium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及中药领域,具体地说是一种治疗股骨头缺血性坏死的中药,以骨碎补、续断、淫羊藿、葛根、黄芪、丹参、莪术、板蓝根、紫石英为原料,经过合理配伍,剂量调配制成合剂。按上述比例将各原料混合,于过量的水中水浸30‑50min,水浸后将水加热至105‑110℃,而后于该温度下煎煮25‑30min,即得汤剂。可治疗Ⅰ期、Ⅱ期、Ⅲ期股骨头缺血性坏死,尤其针对性治疗激素性股骨头缺血性坏死,本发明通过君药、辅药的科学配伍,具有补益肾气,养血活血壮骨,清热解毒,修复骨小梁组织功能结构的疗效,达到治愈股骨头缺血性坏死的效果。
Description
技术领域
本发明涉及中药领域,具体地说是一种治疗股骨头缺血性坏死的中药。
背景技术
股骨头缺血性坏死(AVN)又称股骨头坏死(ONFH)是股骨头血供中断或受损,引起骨细胞及骨髓成分死亡及随后的修复,继而导致股骨头结构改变、股骨头塌陷、关节功能障碍的疾病,是骨科领域常见的难治性疾病。
股骨头缺血性坏死(aseptic necrosis of the femoral head,ANFH)是一种难治性进展性骨科疾病。随着病情进展,会对患者的生活工作产生严重的不利影响,一旦晚期股骨头严重塌陷,全髋关节置换可能是唯一有效的方法[1]。然而人工关节一般只能使用15~20年,对活动量需求较大的患者而言,需行多次髋关节置换手术。因此防止股骨头塌陷,修复股骨头坏死,保留自身关节,延缓或避免髋关节置换是一种理想策略[2]。
股骨头坏死的X线分期方法很多,一般采用Arlet,Ficat和Hageffard的5期分法:Ⅰ期(前放射线期)此期约有50%的患者可出现轻微髋痛,负重时加重。查体:髋关节活动受限,以内旋活动受限最早出现,强力内旋时髋关节疼痛加重。X线显示:可为阴性,也可见散在性骨质疏松或骨小梁界限模糊。Ⅱ期(坏死形成,头变扁前期)临床症状明显,且较I期加重。X光片显示:股骨头广泛骨质疏松,散在性硬化或囊性变,骨小梁紊乱、中断,部分坏死区,关节间隙正常。Ⅲ期(移行期)临床症状继续加重。X光片显示:股骨头轻度变扁,塌陷在2mm以内,关节间隙轻度变窄。Ⅳ期(塌陷期)临床症状较重。下肢功能明显受限,疼痛多缓解或消失,患肢肌肉萎缩。X光片显示:股骨头外轮廓和骨小梁紊乱、中断,有半月征,塌陷大于2mm,有死骨形成,头变扁,关节间隙变窄。Ⅴ期(骨关节炎期)临床症状类似骨性关节炎表现,疼痛明显,关节活动范围严重受限。X光片显示:股骨头塌陷,边缘增生,关节间隙融合或消失,髋关节半脱位。
股骨头坏死(osteonecrosisofthefemoralhead,ONFH)分为创伤性及非创伤性两种类型。好发于30~50岁男性,65%~80%的患者会进展到股骨头塌陷,是临床多发病、疑难病之一。创伤性骨坏死主要由于股骨颈骨折、股骨头创伤引起,现临床病例逐渐减少;非创伤性主要是特异性骨坏死、肾上腺皮质类固醇引起的骨坏死、减压性骨坏死、放射后骨坏死、血色蛋白病引起的骨坏死;其中,肾上腺皮质类固醇引起的骨坏死,即激素性骨坏死发生率处于高位,尤其以股骨头坏死发生率最高。
临床上激素性股骨头坏死(SANFH)已居非创伤性ONFH首位,SANFH发病机制目前尚不明确,主要有如下几种学说,脂质代谢紊乱学说、血管内凝血学说等。对可能形成的SANFH进行早期干预,可大大降低其发生率及致残率。目前,中医药治疗股骨头坏死已取得一定的疗效,对许多临床病例能起到缓解疼痛、改善功能的作用,逐渐成为患者的首选。激素性股骨头坏死(SANFH)的治疗依然是研究的热点、难点。当前对于激素性股骨头坏死领域的研究逐渐呈现以下两个趋势:一是随着分子生物学、干细胞研究、细胞凋亡研究的不断发展;二是个体间对激素的敏感性差异越来越受到重视,越来越多的多态性基因被发现与激素性股骨头坏死的发病呈相关性。通过降脂、抗凝、活血通络等方法治疗激素性股骨头坏死,都取得了一定的疗效。随着糖皮质激素类药物在临床中的广泛使用,SANFH的发病率呈现逐年增高的趋势。该病发病隐匿,早期诊断困难,临床发现时往往已经进展为股骨头坏死塌陷以及骨性关节炎,引起髋关节疼痛、功能障碍,甚至致残。相关研究显示,多种细胞因子及相关血清介质如血管内皮细胞生长因子(VEGF)、碱性磷酸酶(AKP)及骨钙素(BGP)等参与了股骨头坏死的骨组织的修复。因此,通过调节上述细胞因子或介质,改善患者坏死股骨头症状,增强患者骨密度及髋关节功能,提高患者劳动活动能力及改善预后就显得十分有意义。
目前临床上常用的治疗股骨头缺血性坏死的中药大多以活血化瘀、补益肝肾为主,没有清热解毒,化淤降浊的中药进行配伍。中医讲的淤浊,类似于现代病理的高血脂、高凝状态产物,其阻塞血管,形成无菌性炎症反应,破坏血管壁。激素性股骨头坏死发病机制目前研究,主要有脂质代谢紊乱学说、血管内凝血等学说。
发明内容
本发明的目的在于提供一种治疗股骨头缺血性坏死的中药。
为实现上述目的,本发明采用的技术方案为:
一种治疗股骨头缺血性坏死的中药,由下述重量配比的原料制成:骨碎补4-15份、续断4-15份、莪术2-10份、板蓝根4-20份、紫石英3-25份、淫羊藿3-18份、葛根3-15份、黄芪4-30份、丹参4-30份;
优选的由下述重量配比的原料制成:骨碎补8-12份、续断8-12份、莪术4-8份、板蓝根8-16份、紫石英10-16份、淫羊藿6-10份、葛根6-10份、黄芪10-16份、丹参10-16份;
最优为由下述重量配比的原料制成:骨碎补10份、续断10份、莪术6份、板蓝根12份、紫石英12份、淫羊藿8份、葛根8份、黄芪12份、丹参12份。
所述的治疗股骨头缺血性坏死的中药的制备方法,按上述比例将各原料混合,于过量的水中水浸30-50min,水浸后将水加热至105-110℃,而后于该温度下煎煮25-30min,即得汤剂。
所述中药还可以制成散剂、片剂、胶囊剂或颗粒剂。
骨碎补,取砂子置锅内炒热200℃以上,加入拣净的骨碎补,烫炒至鼓起,毛呈焦黄色,迅速取出,筛去砂,放凉后除去毛备用;
续断、黄芪、葛根、丹参、莪术、板蓝根,分别洗净切片阴干备用;
淫羊藿,上锅蒸60min,晒干,反复三次,备用;
紫石英,取净洁的紫石英块,用黏土包裹,置入无烟的火炉内煅红透,去掉黏土,倒入醋盆中淬酥,取出,再反复煅淬两次,研末水飞,晾干,备用(每紫石英100kg,用醋15~20L)。
骨碎补、续断、淫羊藿,均为味苦,性温,归肝、肾经,具有补肝肾,强筋骨,疗折伤,止疼痛的功效,是为本发明中药的君药,用于跌扑闪挫,筋骨折伤,肝肾不足,肾阳虚衰,阳痿遗精,肾虚腰痛,筋骨痿软,风湿痹痛。现代药理研究骨碎补能促进骨钙吸收,改善软骨细胞;续断能促进断骨生长、镇痛、促进组织再生;淫羊藿具有促进造血干细胞生成,促进骨细胞DNA合成的作用。
丹参,苦,微寒,归心、肝经,活血祛瘀,通经止痛,清心除烦,凉血消痈,用于气虚乏力,食少便溏,中气下陷,气虚水肿,内热消渴,血虚萎黄,半身不遂,痹痛麻木,痈疽难溃,久溃不敛。
黄芪,味苦,性微温,归肺、脾经,补气升阳,固表止汗,利水消肿,生津养血,行滞通痹,托毒排脓,敛疮生肌。用于气虚乏力,食少便溏,中气下陷,气虚水肿,内热消渴,血虚萎黄,半身不遂,痹痛麻木,痈疽难溃,久溃不敛。
莪术,味苦,甘,性温,归肝、脾经,具有行气破血,消积止痛作用,用于癥瘕痞块,瘀血经闭,胸痹心痛;葛根,味甘,辛,性凉,归脾、胃、肺经,有解肌退热,生津止渴,升阳止泻,通经活络,解酒毒的功效,用于外感头痛,项背强痛,胸痹心疼,酒毒伤中。
丹参、黄芪、葛根与莪术共为辅佐药。现代药理研究黄芪、葛根有雌激素样作用,抑制破骨;莪术具有止痛作用。
板蓝根,味苦,性寒,归心、胃经,具清热解毒,凉血利咽功效,用于温疫时毒,发热咽痛,温毒发斑,丹毒,痈肿。
紫石英,味甘,性温,归肾、心、肺经,有温肾暖宫,镇心安神,温肺平喘功效,用于肾阳亏虚,宫冷不孕,惊悸不安,失眠多梦,虚寒咳喘,有温暖下元的功效。
板蓝根与紫石英在中药中具有佐使作用。现代药理研究板蓝根具有改善血液循环的作用;紫石英,味甘,性温,归心、肝经,安心定神,养血祛湿,通奇脉,镇上冲之气,紫石英主要成分为氟化钙,增加骨钙,促进生长骨骼。
本发明中药采用黄芪、葛根补气养血升阳疏通督脉,既有雌激素样作用,提高人体免疫力,又能抑制破骨细胞活动,促进成骨细胞形成,增加毛细血管抗炎能力;用板蓝根不但有清热解毒,控制无菌性炎症反应的作用,又具有改善血液循环的作用。与改善骨代谢、促进成骨的骨碎补、续断、淫羊藿配伍,促进生髓壮骨作用,可以控制致病因素,修复病变血管,促进骨生长,重建骨小梁恢复骨骼完整结构。
本发明从中医辨证观念出发,提出SANFH的致病因素中有热毒内蕴的因素。以“活血补肾,清热解毒”为激素性股骨头缺血性坏死的治疗原则。“分清泌浊”,降脂抗凝,修复血管,疏通经络,显著改善股骨头血循环,促进骨坏死修复,恢复股骨头功能。
如果病情处于急性期,使用本发明的治疗股骨头缺血性坏死的中药前,需待疾病进入稳定期后。“急则治标”,“缓则治本”,因此急性期治以化痰除湿清热,活血化瘀通经,使用中药:黄芪50g萆薢15g陈皮15g半夏9g茯苓15g炙甘草6g香附12g厚朴12g白术15g苍术15g黄柏15g牛膝15g熟地20g生地20g山萸肉15g山药15g丹皮15g菟丝子15g枸杞子15g补骨脂15g骨碎补15g红花15g没药10g川断15g炮山甲3g石菖蒲15g丝瓜络15g胆南星6g急性子3g。
本发明的优点:
(1)本发明的中药,可治疗Ⅰ期、Ⅱ期、Ⅲ期股骨头缺血性坏死,尤其针对性治疗激素性股骨头缺血性坏死,本发明通过君药、辅药的科学配伍,具有补益肾气,养血活血壮骨,清热解毒,修复骨小梁组织功能结构的疗效,达到治愈股骨头缺血性坏死的效果。
(2)本发明中药具有明显的雌激素样作用,抑制破骨细胞、促进骨形成,降脂抗凝,改善血循环、补血、止痛。
(3)激素性股骨头缺血性坏死的病理机制:免疫力下降,血管内皮无菌性炎症反应,血脂增高,血液粘稠度增加,股骨头内骨小梁哈弗氏管中的微血管堵塞不通,引起股骨头缺血性坏死。本发明的中药尤其适用于激素性股骨头缺血性坏死,它是以骨碎补、续断、淫羊藿、葛根、黄芪、丹参、莪术、板蓝根、紫石英九种性味为苦甘温的原料,经过合理配伍,剂量调配制成合剂。中药采用黄芪、葛根补气养血升阳疏通督脉,既有雌激素样作用,提高人体免疫力,又能抑制破骨细胞活动,促进成骨细胞形成,增加毛细血管抗炎能力;用板蓝根不但有清热解毒,控制无菌性炎症反应的作用,又具有改善血液循环的作用。与改善骨代谢、促进成骨的骨碎补、续断、淫羊藿配伍,促进生髓壮骨作用,可以控制致病因素,修复病变血管,促进骨生长,重建骨小梁恢复骨骼完整结构。
附图说明
图1为出诊DR片,其中a为主视DR片,b为右侧DR片,c为左侧DR片。
图2为服药两年后复查DR片。
图3为停药一年后复查MRI片,a为主视MRI片,b为俯视MRI片。
图4为治疗前CT片。
图5为治疗前DR片。
图6为治疗后CT片。
具体实施方式
实施例1
按下述重量配比称取中草药原料:
骨碎补10份、续断10份、莪术6份、板蓝根12份、紫石英12份、淫羊藿8份、葛根8份、黄芪12份、丹参12份;
骨碎补,取砂子置锅内炒热200℃以上,加入拣净的骨碎补,烫炒至鼓起,毛呈焦黄色,迅速取出,筛去砂,放凉后除去毛备用;续断、黄芪、葛根、丹参、莪术、板蓝根,洗净切片阴干备用;淫羊藿,上锅蒸60min,晒干,反复三次,备用;紫石英,取净洁的紫石英块,用黏土包裹,置入无烟的火炉内煅红透,去掉黏土,倒入醋盆中淬酥,取出,再反复煅淬两次,研末水飞,晾干备用;每紫石英100kg,用醋15L。
按上述比例将各原料混合,于过量的水中水浸泡30min,水浸后将水加热至110℃,而后于该温度下煎煮25min,即得汤剂。
实施例2
骨碎补15份、续断15份、淫羊藿18份、葛根15份、黄芪30份、丹参30份、莪术10份、板蓝根20份、紫石英25份;
骨碎补,取砂子置锅内炒热200℃以上,加入拣净的骨碎补,烫炒至鼓起,毛呈焦黄色,迅速取出,筛去砂,放凉后除去毛备用;续断、黄芪、葛根、丹参、莪术、板蓝根,洗净切片阴干备用;淫羊藿,上锅蒸60min,晒干,反复三次,备用;紫石英,取净洁的紫石英块,用黏土包裹,置入无烟的火炉内煅红透,去掉黏土,倒入醋盆中淬酥,取出,再反复煅淬两次,研末水飞,晾干备用;每紫石英100kg,用醋15L。
按上述比例将各原料混合,于过量的水中水浸泡30min,水浸后将水加热至105℃,而后于该温度下煎煮30min,即得汤剂。
实施例3
按下述重量配比称取中草药原料:
骨碎补4份、续断4份、淫羊藿3份、葛根3份、黄芪4份、丹参4份、莪术2份、板蓝根4份、紫石英3份;
骨碎补,取砂子置锅内炒热200℃以上,加入拣净的骨碎补,烫炒至鼓起,毛呈焦黄色,迅速取出,筛去砂,放凉后除去毛备用;续断、黄芪、葛根、丹参、莪术、板蓝根,洗净切片阴干备用;淫羊藿,上锅蒸60min,晒干,反复三次,备用;紫石英,取净洁的紫石英块,用黏土包裹,置入无烟的火炉内煅红透,去掉黏土,倒入醋盆中淬酥,取出,再反复煅淬两次,研末水飞,晾干备用;每紫石英100kg,用醋15L。
按上述比例将各原料混合,于过量的水中水浸泡30min,水浸后将水加热至105℃,而后于该温度下煎煮25min,即得汤剂。
实施例4
按下述重量配比称取中草药原料:
骨碎补10份、续断10份、淫羊藿8份、葛根8份、黄芪12份、丹参12份、莪术6份、板蓝根12份、紫石英12份;
骨碎补,取砂子置锅内炒热,加入拣净的骨碎补,烫炒至鼓起,毛呈焦黄色,迅速取出,筛去砂,放凉后除去毛备用,续断、黄芪、葛根、丹参、莪术、板蓝根,洗净切片阴干备用;淫羊藿,上锅蒸60min,晒干,反复三次,备用,紫石英,取净洁的紫石英块,用黏土包裹,置入无烟的火炉内煅红透,去掉黏土,倒入醋盆中淬酥,取出,再反复煅淬两次,研末水飞,晾干备用;
取上述比例中药原料混合磨成细粉,过120目筛后,制成散剂。
将上述中药中原料根据现有制备方式还可将其制备成散剂、片剂、胶囊剂或颗粒剂。
临床病例1
张某,男,27岁,初诊症状双髋关节疼痛,活动受限2个月,曾因其他疾病多次静脉滴注地塞米松注射液,双髋关节疼痛,跛行,不能盘腿。查体:双髋关节僵硬,屈伸受限,双侧腹股沟中点压痛,双侧“4”字试验阳性。MRI报告:双股骨头关节承重面T1W1可见不均匀信号减低,T2W1呈片状不规则高低混杂信号,左侧股骨头内可见囊性长T2信号影,双侧关节间隙变窄、模糊。DR片示(见图1):图1b为右侧DR见新月征,右侧股骨头见斑点、囊变、硬化带、骨小梁稀疏、新月征,股骨头坏死,受累15%以上,为Ⅲa型;图1c为左侧DR见新月征,左侧股骨头见囊变、硬化带、骨小梁稀疏、新月征,偏向外侧,股骨头塌陷2mm,股骨头受累超过15%-30%,属于Ⅲc型。
舌红,苔少,脉弦。四诊合参,辨证为气滞血瘀,痰湿郁阻。
根据四诊合参,“急则治标”,急性期治以化痰除湿清热,活血化瘀通经,辨证处方如下:黄芪50g萆薢15g陈皮15g半夏9g茯苓15g炙甘草6g香附12g厚朴12g白术15g苍术15g黄柏15g牛膝15g熟地20g生地20g山萸肉15g山药15g丹皮15g菟丝子15g枸杞子15g补骨脂15g骨碎补15g红花15g没药10g川断15g炮山甲3g石菖蒲15g丝瓜络15g胆南星6g急性子3g,14剂,日一剂,分二次水煎服,用药两周疼痛缓解;疾病进入稳定期,中医讲“缓则治本”,补益肝肾,养血活血,清热解毒,生骨壮骨,开始服用实施例1中的中药,口服2次/日,每次150ml,饭后服,忌辛辣、鱼腥、生冷、黏腻之品。
连续服用两年,髋关节疼痛消失,自行活动良好,可以从事发病前的工作,生活自如。DR复查见(见图2):斑点、囊变、硬化带、骨小梁稀疏、新月征均消失,骨小梁显著增加,排列有序,关节面光滑。查体见患者双髋关节屈伸活动正常,无压痛,“4”字试验阴性,行走自如,无跛行,治愈。三年后复查DR片所示(图3):右侧股骨头骨小梁排列整齐有序、致密,头型完好,无异常可见;左侧股骨头骨小梁致密,关节面光滑,除头高度下沉2mm外,无其他异常。关节活动正常,无不适,可以从事日常工作活动。
临床病例2
佟某某,女,49岁,初诊左髋部疼痛,跛行1年。因患哮喘病,服用激素史。查体见左髋关节屈伸受限,“4”字试验阳性,左腹股沟中点压痛。MRI检查见:左股骨头形态改变,关节间隙改变,股骨头内高低信号影混杂不均,关节腔积液;CT平扫见(图4):股骨头关节面扁平改变,左股骨头内囊性变,骨小梁不规整,有硬化区。诊断为左侧股骨头缺血性坏死(Ⅲ期)。DR片(图5):左侧股骨头可见密度不均,有囊变区。服用实施例2的中药,每日2次,每次150ml,饭后服,忌辛辣、鱼腥、生冷、黏腻之品。服药13个月后,左髋关节无疼痛,活动不受限,可行走2公里,自觉双髋酸胀感,无痛。复查CT片(图6):左股骨头形态正常,无空洞囊变,骨密度显著增加,骨小梁增粗密集,达到骨性愈合。
选取112例股骨头坏死的患者,服用实施例1中的中药,口服2次/日,每次150ml,连续服用2年。通过X线观察评价,不再继续塌陷33例,坏死区不继续扩大38例,骨小梁明显增多密集41例。本发明的治疗股骨头缺血性坏死的中药具有促进骨生长,重建骨小梁恢复骨骼完整结构的作用。
对比例1:
上述实施例1的中药与仙灵骨葆胶囊(黄艳军,仙灵骨葆胶囊治疗股骨头坏死的临床疗效观察及相关护理措施分析,Strait Pharmaceutical Journal[J].2017,29(6):203-204.)的对比。
选取44例股骨头坏死的患者,服用实施例1中的中药,口服2次/日,每次150ml,连续服用2年。治愈程度优为23例,良为16例,可为4例,差为1例,优良率见表1。
表1治疗效果%
优,是指患者的疼痛感与关节活动性得到明显改善;良,是指患者的疼痛感与关节,活动性得到了较大的改善;可,是指患者的疼痛感与关节活动性得到了一定地改善;无效,是指患者的疼痛感与关节活动性未减轻或出现恶化现象(黄艳军,仙灵骨葆胶囊治疗股骨头坏死的临床疗效观察及相关护理措施分析,Strait Pharmaceutical Journal[J].2017,29(6):203-204.)。
从表1中可以看出,本发明的治疗股骨头缺血性坏死的中药优良率显著高于仙灵骨葆胶囊。
参考文献:
[1]Ye Y H,Chen K,Jin K K,et al.[Progress on surgical treatment forfemoral head-preservering in the precollapse stage of femoral head necrosis][J].Zhongguo Gu Shang,2017,30(3):287-292.
[2]Issa K,Pivec R,Kapadia B H,et al.Osteonecrosis of the femoralhead:the total hip replacement solution[J].Bone Joint J,2013,95-B(11 SupplA):46-50.
Claims (5)
1.一种治疗激素性股骨头缺血性坏死的中药,其特征在于:由下述重量配比的原料制成:骨碎补4-15份、续断4-15份、莪术2-10份、板蓝根4-20份、紫石英3-25份、淫羊藿3-18份、葛根3-15份、黄芪4-30份、丹参4-30份。
2.按照权利要求1所述的治疗激素性股骨头缺血性坏死的中药,其特征在于:由下述重量配比的原料制成:骨碎补8-12份、续断8-12份、莪术4-8份、板蓝根8-16份、紫石英10-16份、淫羊藿6-10份、葛根6-10份、黄芪10-16份、丹参10-16份。
3.按照权利要求2所述的治疗激素性股骨头缺血性坏死的中药,其特征在于:由下述重量配比的原料制成:骨碎补10份、续断10份、莪术6份、板蓝根12份、紫石英12份、淫羊藿8份、葛根8份、黄芪12份、丹参12份。
4.一种权利要求 1-3任一项所述的治疗激素性股骨头缺血性坏死的中药的制备方法,其特征在于:按上述比例将各原料混合,于过量的水中水浸30-50min,水浸后将水加热至105-110℃,而后于该温度下煎煮25-30min,即得汤剂。
5.按照权利要求4所述的治疗激素性股骨头缺血性坏死的中药的制备方法,其特征在于:所述中药制成散剂、片剂、胶囊剂或颗粒剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811071479.2A CN108785617B (zh) | 2018-09-14 | 2018-09-14 | 一种治疗股骨头缺血性坏死的中药 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811071479.2A CN108785617B (zh) | 2018-09-14 | 2018-09-14 | 一种治疗股骨头缺血性坏死的中药 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108785617A CN108785617A (zh) | 2018-11-13 |
CN108785617B true CN108785617B (zh) | 2021-06-01 |
Family
ID=64081965
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811071479.2A Active CN108785617B (zh) | 2018-09-14 | 2018-09-14 | 一种治疗股骨头缺血性坏死的中药 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108785617B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1569199A (zh) * | 2004-04-27 | 2005-01-26 | 武英 | 一种治疗股骨头无菌性坏死药的配方 |
CN103263480A (zh) * | 2013-05-31 | 2013-08-28 | 北京振东光明药物研究院有限公司 | 一种用于治疗股骨头坏死的药物组合物及其制备方法 |
CN104826026A (zh) * | 2015-05-23 | 2015-08-12 | 济南邦文医药科技有限公司 | 一种治疗肝肾亏虚痰瘀互结型中晚期股骨头坏死的中药 |
-
2018
- 2018-09-14 CN CN201811071479.2A patent/CN108785617B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1569199A (zh) * | 2004-04-27 | 2005-01-26 | 武英 | 一种治疗股骨头无菌性坏死药的配方 |
CN103263480A (zh) * | 2013-05-31 | 2013-08-28 | 北京振东光明药物研究院有限公司 | 一种用于治疗股骨头坏死的药物组合物及其制备方法 |
CN104826026A (zh) * | 2015-05-23 | 2015-08-12 | 济南邦文医药科技有限公司 | 一种治疗肝肾亏虚痰瘀互结型中晚期股骨头坏死的中药 |
Non-Patent Citations (2)
Title |
---|
益肾祛瘀壮骨中药治疗无菌性股骨头坏死疗效及对骨密度的影响;葛永潮等;《现代中西医结合杂志》;20170501;第26卷(第13期);第1423-1425页 * |
补肾复活汤治疗中老年股骨头缺血性坏死的临床观察;曾炎辉;《广州中医药大学学报》;20050430;第22卷(第2期);第94-97页 * |
Also Published As
Publication number | Publication date |
---|---|
CN108785617A (zh) | 2018-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104547790A (zh) | 一种治疗风湿性关节炎的中药组合物及其制备方法 | |
CN101612272A (zh) | 一种治疗风湿、类风湿疾病的中药 | |
CN104043049A (zh) | 一种治疗乳腺增生的中药组合物 | |
CN100998722B (zh) | 一种治疗月经后期痛经的内服中药 | |
CN104306540B (zh) | 一种治疗脑瘤术后肢体麻木的中药制剂及其制备方法 | |
CN103263601B (zh) | 一种加速骨折手术后愈合速度的中药制剂及制备方法 | |
CN104474473A (zh) | 一种治疗妇科炎症的中药组合物及其制备方法 | |
CN103446360B (zh) | 治疗腰椎间盘突出的中药胶囊制剂及其制备方法 | |
CN108785617B (zh) | 一种治疗股骨头缺血性坏死的中药 | |
CN101569711A (zh) | 一种治疗酒糟鼻的药及其制备方法 | |
CN104857311A (zh) | 一种治疗缺血性股骨头坏死的中药 | |
CN100518788C (zh) | 一种治疗肿瘤的药物 | |
CN104161805B (zh) | 一种治疗股骨头坏死的中药及制备方法 | |
CN103610893B (zh) | 一种治疗冠心病的中药 | |
CN104857440A (zh) | 一种治疗肾虚血瘀型中晚期股骨头坏死的中药及其制备方法 | |
CN104826026A (zh) | 一种治疗肝肾亏虚痰瘀互结型中晚期股骨头坏死的中药 | |
CN101085303A (zh) | 一种内服治疗乳腺增生的中药组合物 | |
CN104623544A (zh) | 中度脂肪肝健脾燥湿中药剂及制备方法 | |
CN104435549A (zh) | 一种治疗风寒湿痹型股骨头坏死的中药 | |
CN104338052A (zh) | 治疗脑血栓的中药配方 | |
CN103690833B (zh) | 一种治疗风湿性关节炎的中药 | |
CN102988762A (zh) | 治疗外伤骨折的膏药 | |
CN104000999A (zh) | 一种治疗股骨头缺血性坏死的中药组合物 | |
CN1236804C (zh) | 一种治痔胶囊的制法 | |
CN101112497A (zh) | 一种治疗前列腺炎的药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |